Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding
- 1 May 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 372 (2) , 199-206
- https://doi.org/10.1016/s0014-2999(99)00205-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Distinction between surmountable and insurmountable selective AT1receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1receptorsBritish Journal of Pharmacology, 1999
- Molecular pharmacology of LR-B/081, a new non-peptide angiotensin AT1 receptor antagonistEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Kinetic studies on the interaction of nonlabeled antagonists with the angiotensin II receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Non-peptide Angiotensin Agonist: FUNCTIONAL AND MOLECULAR INTERACTION WITH THE AT1 RECEPTORPublished by Elsevier ,1995
- Pharmacological Properties of KT3–671, a Novel Nonpeptide Angiotensin II Receptor AntagonistJournal of Cardiovascular Pharmacology, 1995
- Agonist-antagonist interactions at angiotensin receptors: application of a two-state receptor modelTrends in Pharmacological Sciences, 1994
- Internalization of the rat AT1a and AT1b receptors: pharmacological and functional requirementsFEBS Letters, 1994
- The serotonin‐S2 Receptor: A receptor‐transducer coupling model to explain insurmountable antagonist effectsDrug Development Research, 1986
- Desensitization, two-state receptors and pharmacological parametersJournal of Theoretical Biology, 1983
- The kinetics of action of acetylcholine antagonists in smooth muscleProceedings of the Royal Society of London. B. Biological Sciences, 1966